1
|
Butler IS, Gilson DF, Jean-Claude BJ, Mostafa SI. Synthesis of new 4-methylesculetin complexes as anti-neoplastic agents and X-ray structure of dimeric bis-bipyridyl-bis-4-methylesculetinato zinc(II). Inorganica Chim Acta 2014. [DOI: 10.1016/j.ica.2014.05.048] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
2
|
Chand K, Shirazi AN, Yadav P, Tiwari RK, Kumari M, Parang K, Sharma SK. Synthesis and antiproliferative and c-Src kinase inhibitory activities of cinnamoyl- and pyranochromen-2-one derivatives. CAN J CHEM 2013; 91:741-754. [DOI: 10.1139/cjc-2013-0053] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/09/2024]
Abstract
A series of 6- and 8-cinnamoylchromen-2-one and dihydropyranochromen-2-one derivatives were synthesized and their antiproliferative activities were evaluated against three human cancer cell lines, i.e., ovarian adenocarcinoma (SK-OV-3), leukemia (CCRF-CEM), and breast carcinoma (MCF-7). In general, 8-cinnamoylchromen-2-one derivatives were found to have higher antiproliferative activity against the cancer cells when compared with 6-cinnamoyl analogues. Among all of the hybrid chromen-2-one − chalcone/flavanone compounds, a 7-hydroxy-8-cinnamoylchromen-2-one derivative 35 was found to be consistently active against all the cancer cell lines and inhibited the cell proliferation of SK-OV-3, CCRF-CEM, and MCF-7 by 63%, 50%, and 43%, respectively, at a concentration of 50 μmol/L after 72 h of incubation. This compound also exhibited the highest Src kinase inhibition (IC50= 14.5 μmol/L). Structure−activity relationship studies provided insights for designing the next generation of chromen-2-one − chalcone hybrid prototypes and the development of new leads as anticancer agents and (or) Src kinase inhibitors.
Collapse
Affiliation(s)
- Karam Chand
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Amir Nasrolahi Shirazi
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USA
| | - Preeti Yadav
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Rakesh K. Tiwari
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USA
| | - Meena Kumari
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Keykavous Parang
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USA
| | - Sunil K. Sharma
- Department of Chemistry, University of Delhi, Delhi 110007, India
| |
Collapse
|
3
|
Huang XY, Shan ZJ, Zhai HL, Li LN, Zhang XY. Molecular Design of Anticancer Drug Leads Based on Three-Dimensional Quantitative Structure–Activity Relationship. J Chem Inf Model 2011; 51:1999-2006. [DOI: 10.1021/ci2002236] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Xiao Yan Huang
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, People's Republic of China
| | - Zhi Jie Shan
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, People's Republic of China
| | - Hong Lin Zhai
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, People's Republic of China
| | - Li Na Li
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, People's Republic of China
| | - Xiao Yun Zhang
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, People's Republic of China
| |
Collapse
|
4
|
Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, Blagg BSJ. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. J Org Chem 2008; 73:2130-7. [PMID: 18293999 DOI: 10.1021/jo702191a] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Recent studies have shown that the DNA gyrase inhibitor, novobiocin, binds to a previously unrecognized ATP-binding site located at the C-terminus of Hsp90 and induces degradation of Hsp90-dependent client proteins at approximately 700 microM. As a result of these studies, several analogues of the coumarin family of antibiotics have been reported and shown to exhibit increased Hsp90 inhibitory activity; however, the monomeric species lacked the ability to manifest anti-proliferative activity against cancer cell lines at concentrations tested. In an effort to develop more efficacious compounds that produce growth inhibitory activity against cancer cell lines, structure-activity relationships were investigated surrounding the prenylated benzamide side chain of the natural product. Results obtained from these studies have produced the first novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
Collapse
Affiliation(s)
- Joseph A Burlison
- Department of Medicinal Chemistry, 1251 Wescoe Hall Drive, Malott 4070, The University of Kansas, Lawrence, Kansas 66045-7563, USA
| | | | | | | | | | | |
Collapse
|
5
|
Abstract
The DNA gyrase inhibitor, novobiocin, was recently shown to inhibit Hsp90 via a previously unrecognized C-terminal ATP-binding site. Previous structure-activity relationship studies identified key moieties that appear important for Hsp90 inhibitory activity. In an effort to provide a more efficacious lead compound, a parallel library of noviosylated coumarin analogues was prepared.
Collapse
Affiliation(s)
- Yung-Tzung Huang
- Department of Medicinal Chemistry and The Center for Chemical Methodologies and Library Development, The University of Kansas, 1251 Wescoe Hall Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, USA
| | | |
Collapse
|
6
|
Shaw SJ, Menzella HG, Myles DC, Xian M, Smith AB. Coumarin-derived discodermolide analogues possessing equivalent antiproliferative activity to the natural product—a further simplification of the lactone region. Org Biomol Chem 2007; 5:2753-5. [PMID: 17700839 DOI: 10.1039/b708884c] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Analogues of discodermolide in which the complete C-1 to C-7 fragment is replaced with a coumarin moiety display equivalent potency to that of the natural product.
Collapse
Affiliation(s)
- Simon J Shaw
- Kosan Biosciences, Inc., 3832 Bay Center Place, Hayward, CA 94545, USA.
| | | | | | | | | |
Collapse
|
7
|
|